This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Dsm IP Assets B.v., Hoffmann-La Roche Inc.. Active years: 1996-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-2008
Title: The Innovations of Peter Hofmann
Introduction
Peter Hofmann is an accomplished inventor based in Weil-Haltingen, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the areas of analytical methods and transdermal drug delivery systems. With a total of 2 patents, Hofmann's work reflects a commitment to advancing medical technology.
Latest Patents
Hofmann's latest patents include a method for the determination of 25-hydroxycholecalciferol in feed. This innovative method involves adding a defined amount of an internal standard to an aqueous dispersion of the feed, followed by extraction and processing using HPLC and mass spectrometry. His second patent focuses on a pharmaceutical composition for transdermal delivery, which comprises an effective amount of an active ingredient selected from benzodiazepines and their antagonists, along with various excipients to enhance absorption.
Career Highlights
Throughout his career, Hofmann has worked with notable companies such as DSM IP Assets B.V. and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical formulations and analytical techniques.
Collaborations
Hofmann has collaborated with esteemed colleagues, including Richard Goessl and Laurent Denu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field.
Conclusion
Peter Hofmann's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant innovator. His work continues to influence the development of effective drug delivery systems and analytical methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

